{
  "symbol": "NIVFW",
  "company_name": "Newgenivf Group WT",
  "ir_website": "https://investors.newgenivf.com/",
  "structured_data": [
    {
      "section_name": "Error Details",
      "links": [
        {
          "title": "ERR_HTTP2_PROTOCOL_ERROR",
          "url": "https://investors.newgenivf.com/#ERR_HTTP2_PROTOCOL_ERROR",
          "content": "[Skip to content](#lfg-main-content)\n\n# Investor Relations\n\n## Company Profile\n\nNewGenIVF Group Limited is an assisted reproductive services (“ARS”) provider in Asia Pacific helping couples and individuals obtain access to fertility treatments. With a mission to assist couples and individuals in building families regardless of fertility challenges, NewGenIVF Group Limited has dedicated itself to creating increased access to fertility treatments and providing mainly two services: (i) in-vitro fertilization (“IVF”) treatment service, comprising traditional IVF and egg donation; and (ii) surrogacy and ancillary caring services. NewGenIVF Group Limited and its management have considerable experience in the ARS market and the broader healthcare industry. NewGenIVF Group Limited’s clinics are located in Thailand, Cambodia, and Kyrgyzstan.\n\nMinimum 15 minutes delayed. Source: LSEG\n\n[More](/stock/stock-quote-chart \"View more stock information\")\n\n## News Releases\n\n22.11.2024 \n\n[NewGenIvf Receives Nasdaq Delisting Notice and Plans to Submit Appeal, Announces Strategic Path Forward to Regain Compliance](/news-releases/news-release-details/newgenivf-receives-nasdaq-delisting-notice-and-plans-submit)\n\n18.11.2024 \n\n[NewGenIvf Enters into a Binding Term Sheet with White Lion Capital for $100 Million Equity Line of Credit, Expandable to $500 Million](/news-releases/news-release-details/newgenivf-enters-binding-term-sheet-white-lion-capital-100)\n\n14.10.2024 \n\n[NewGenIvf Receives Nasdaq Notification Regarding Minimum Bid Price](/news-releases/news-release-details/newgenivf-receives-nasdaq-notification-regarding-minimum-bid)\n\n[View All](/news-events/news-releases \"View more releases\")\n\n## Events\n\nMore events are coming soon.\n\n[View All](/news-events/events \"View more events\")\n\n## SEC Filings\n\n22.11.2024\n\n[Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act](/sec-filings/sec-filing/6-k/0001213900-24-101207)\n\nForm Type: [6-K](/sec-filings/sec-filing/6-k/0001213900-24-101207)\n\n22.11.2024\n\n[Registration statement for certain foreign private issuers](/sec-filings/sec-filing/f-1/0001213900-24-101682)\n\nForm Type: [F-1](/sec-filings/sec-filing/f-1/0001213900-24-101682)\n\n18.11.2024\n\n[Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act](/sec-filings/sec-filing/6-k/0001213900-24-099350)\n\nForm Type: [6-K](/sec-filings/sec-filing/6-k/0001213900-24-099350)\n\n[View All](/financials/sec-filings \"View more filings\")\n"
        }
      ]
    }
  ]
}